Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2008 | 1 |
2010 | 1 |
2022 | 1 |
2023 | 1 |
2024 | 0 |
Search Results
4 results
Results by year
Filters applied: . Clear all
Page 1
Nasal symmetry after different techniques of primary lip repair for unilateral complete cleft lip with or without cleft of the alveolus and palate: A systematic review.
J Craniomaxillofac Surg. 2022 Dec;50(12):894-909. doi: 10.1016/j.jcms.2022.12.006. Epub 2023 Jan 5.
J Craniomaxillofac Surg. 2022.
PMID: 36635151
Review.
Assessment of the risk of bias of the included randomized controlled trials (RCTs) (N-1) was done with the Cochrane Risk of Bias 2 (RoB-2) tool, and the ROBINS-I tool was used for non-randomized studies (n = 14). ...
Assessment of the risk of bias of the included randomized controlled trials (RCTs) (N-1) was done with the Cochrane Risk of Bias 2 (RoB …
Injection therapy and denervation procedures for chronic low-back pain: a systematic review.
Henschke N, Kuijpers T, Rubinstein SM, van Middelkoop M, Ostelo R, Verhagen A, Koes BW, van Tulder MW.
Henschke N, et al.
Eur Spine J. 2010 Sep;19(9):1425-49. doi: 10.1007/s00586-010-1411-0. Epub 2010 Apr 29.
Eur Spine J. 2010.
PMID: 20424870
Free PMC article.
Review.
Two review authors independently assessed studies for eligibility and risk of bias (RoB). A meta-analysis was performed with clinically homogeneous studies, and the GRADE approach was used to determine the quality of evidence. In total, 27 RCTs were included, 14 on injecti …
Two review authors independently assessed studies for eligibility and risk of bias (RoB). A meta-analysis was performed with clinical …
Item in Clipboard
Daily intranasal palivizumab to prevent respiratory syncytial virus infection in healthy preterm infants: a phase 1/2b randomized placebo-controlled trial.
Mazur NI, Löwensteyn YN, Terstappen J, Leusen J, Schobben F, Cianci D, van de Ven PM, Nierkens S, Bont LJ; Narsyn Study Group.
Mazur NI, et al.
EClinicalMedicine. 2023 Nov 25;66:102324. doi: 10.1016/j.eclinm.2023.102324. eCollection 2023 Dec.
EClinicalMedicine. 2023.
PMID: 38192587
Free PMC article.
Item in Clipboard
A pharmacokinetic and pharmacogenetic study of efavirenz in children: dosing guidelines can result in subtherapeutic concentrations.
ter Heine R, Scherpbier HJ, Crommentuyn KM, Bekker V, Beijnen JH, Kuijpers TW, Huitema AD.
ter Heine R, et al.
Antivir Ther. 2008;13(6):779-87.
Antivir Ther. 2008.
PMID: 18839779
Item in Clipboard
Cite
Cite